Cardinal Health, Inc. (CAH) Tops Q2 EPS by 5c, Raises FY12 EPS Guidance
Cardinal Health, Inc. (NYSE: CAH) reported Q2 EPS of $0.81, $0.05 better than the analyst estimate of $0.76. Revenue for the quarter came in at $27.1 million versus the consensus estimate of $26.89 million.
Cardinal Health, Inc. sees FY2012 EPS of $3.10-$3.20, versus prior guidance of $3.04-$3.19 and the consensus of $3.18.
For earnings history and earnings-related data on Cardinal Health, Inc. (CAH) click here.
Cardinal Health, Inc. sees FY2012 EPS of $3.10-$3.20, versus prior guidance of $3.04-$3.19 and the consensus of $3.18.
For earnings history and earnings-related data on Cardinal Health, Inc. (CAH) click here.
